Assessment of Plasma Oxalate Concentration in Patients With CKD

慢性肾脏病患者血浆草酸盐浓度的评估

阅读:1

Abstract

INTRODUCTION: Alterations in oxalate homeostasis are associated with kidney stone disease and progression of chronic kidney disease (CKD). However, accurate measurement of plasma oxalate (P(Ox)) concentrations in large patient cohorts is challenging as prompt acidification of samples has been deemed necessary. In the present study, we investigated the effects of variations in sample handling on P(Ox) results and examined an alternative strategy to the established preanalytical procedures. METHODS: The effect of storage time at room temperature (RT) and maintenance of samples at -80°C was tested. P(Ox) was measured in 1826 patients enrolled in the German Chronic Kidney Disease (GCKD) study, an ongoing multicenter, prospective, observational cohort study. RESULTS: We demonstrate that P(Ox) concentrations increased rapidly when samples were maintained at RT. This was most relevant for P(Ox) <10 μM, as concentrations more than doubled within a few hours. Immediate freezing on dry ice and storage at -80°C provided stable results and allowed postponement of acidification for >1 year. In the patients of the lowest estimated glomerular filtration rate (eGFR) quartile, median P(Ox) was 2.7 μM (interquartile range [IQR] <2.0-4.2) with a median eGFR of 25.1 ml/min per 1.73 m(2) (IQR 20.3-28.1). CONCLUSION: We conclude that immediate freezing and maintenance of plasma samples at -80°C facilitates the sample collection process and allows accurate P(Ox) assessment in large cohorts. The present study may serve as a reference for sample handling to assess P(Ox) in clinical trials and to determine its role in CKD progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。